{"cursor":"4741","size":15,"audio":[],"currentlang":"en","article":"{{Drugbox\n| Verifiedfields = changed verifiedrevid = 458275071 image =\n\n\n| type = mab mab_type = mab source = u target = TNFα\n\n\n| tradename = Simponi Drugs.com = MedlinePlus = a610010 licence_EU = Simponi\n| licence_US = Golimumab pregnancy_AU = pregnancy_US = pregnancy_category =\n| legal_AU = legal_CA = legal_UK = legal_US = Rx-only legal_status =\n| routes_of_administration = Subcutaneous injection\n\n\n| bioavailability = protein_bound = metabolism = elimination_half-life =\n| excretion =\n\n\n| CAS_number_Ref = CAS_number = 476181-74-5 ATC_prefix = L04 ATC_suffix =\n| AB06 PubChem = DrugBank_Ref = DrugBank = UNII_Ref = UNII = 91X1KLU43E\n| KEGG_Ref = KEGG = D04358 ChEMBL_Ref = ChEMBL = 1201833 ChemSpiderID_Ref =\n| ChemSpiderID = NA\n\n\n| C=6530 | H=10068 | N=1752 | O=2026 | S=44 molecular_weight = 147 kDa\n}} 'Golimumab' (CNTO 148) is a human monoclonal antibody which is\nused as an immunosuppressive drug and marketed under the brand name 'Simponi'.\nGolimumab targets tumor necrosis factor alpha (TNF-alpha), a pro-inflammatory\nmolecule [http://www.ama-assn.org/ama1/pub/upload/mm/365/golimumab.doc\nStatement On A Nonproprietary Name Adopted By The USAN Council â Golimumab],\nAmerican Medical Association. and hence is a TNF inhibitor.\n\nGolimumab was developed by Centocor and is approved in Canada Apr\n2009 and the United States [http://www.drugs.com/newdrugs/simponi-golimumab-receives-fda-\napproval-first-once-monthly-anti-tnf-rheumatoid-arthritis-psoriatic-1329.html\nFDA Approves Simponi] as a once monthly subcutaneous treatment for adults\nwith moderately to severely active rheumatoid arthritis, psoriatic arthritis,\nand ankylosing spondylitis. Golimumab is pending FDA\napproval for Ulcerative Colitis.\n\nIn the same year, Johnson & Johnson, the parent company of Centocor, also\nreceived [http://insciences.org/article.php?article_id=7069 an approval] from\nEuropean Medicines Agency (EMEA) for the use of golimumab as a treatment for\nrheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. [http://sev.prnewswire.com/retail/20080415/NYTU07615042008-\n1.html Johnson & Johnson Reports 2008 First-Quarter Results] Golimumab is\nmarketed by Merck & Co, Inc. in Europe, pending final arbitration between J&J\nand Merck. [http://www.latimes.com/business/la-fi-arthritis25-\n2009apr25,0,1270502.story FDA approves Johnson & Johnson rheumatoid arthritis\ndrug golimumab] [http://www.reuters.com/article/idUSN0722206120100907]\nMerck sees fast ruling in J&J Remicade arbitration   {{cite web\n | url=http://www.emea.europa.eu/humandocs/Humans/EPAR/simponi/simponi.htm\n | title= Simponi European Public Assessment Report publisher=European Medicines\n | Agency accessdate=2009-11-15\n}}\n","linknr":505,"url":"golimumab","recorded":1376424208,"links":["/w/index.php?title=Golimumab&action=edit","/w/index.php?title=Golimumab&action=edit","//bits.wikimedia.org/favicon/wikipedia.ico","/w/opensearch_desc.php","//en.wikipedia.org/w/api.php?action=rsd","//creativecommons.org/licenses/by-sa/3.0/","/w/index.php?title=Special:RecentChanges&feed=atom","http://en.wikipedia.org/wiki/Golimumab","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=ext.gadget.DRN-wizard%2CReferenceTooltips%2Ccharinsert%2Cteahouse%7Cext.rtlcite%2Cwikihiero%7Cext.uls.nojs%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmw.PopUpMediaTransform%7Cskins.vector&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=ext.visualEditor.viewPageTarget.noscript&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=startup&only=scripts&skin=vector&*","//bits.wikimedia.org/geoiplookup","//meta.wikimedia.org","#mw-navigation","#p-search","/wiki/Nomenclature_of_monoclonal_antibodies","/wiki/Monoclonal_antibody#Applications","/wiki/File:Engineered_monoclonal_antibodies.svg","/wiki/Monoclonal_antibody#Production","/wiki/Human","/wiki/Antigen","/wiki/TNF%CE%B1","/wiki/Trade_name","/wiki/American_Society_of_Health-System_Pharmacists","/wiki/Drugs.com","http://www.drugs.com/monograph/golimumab.html","/wiki/MedlinePlus","http://www.nlm.nih.gov/medlineplus/druginfo/meds/a610010.html","/wiki/Regulation_of_therapeutic_goods","/wiki/European_Medicines_Agency","http://www.ema.europa.eu/ema/index.jsp?curl=/pages/medicines/landing/epar_search.jsp&murl=menus/medicines/medicines.jsp&searchkwByEnter=true&status=Authorised&keyword=Simponi&searchType=Name&jsenabled=true","/wiki/U.S._Food_and_Drug_Administration","http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Golimumab&SearchType=BasicSearch","/wiki/Pregnancy_category","/wiki/Regulation_of_therapeutic_goods","/wiki/Prescription_drug","/wiki/United_States","/wiki/Route_of_administration","/wiki/Subcutaneous_injection","/wiki/CAS_registry_number","http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?term=476181-74-5&rn=1","//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png","/wiki/Anatomical_Therapeutic_Chemical_Classification_System","/wiki/ATC_code_L04","http://www.whocc.no/atc_ddd_index/?code=L04AB06","/wiki/Unique_Ingredient_Identifier","http://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=91X1KLU43E","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","/wiki/KEGG","http://www.kegg.jp/entry/D04358","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","/wiki/ChEMBL","https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL1201833","//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png","/wiki/Chemical_formula","/wiki/Carbon","/wiki/Hydrogen","/wiki/Nitrogen","/wiki/Oxygen","/wiki/Sulfur","/wiki/Molecular_mass","/wiki/KDa","//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/14px-X_mark.svg.png","/wiki/Wikipedia:WikiProject_Chemicals/Chembox_validation","//en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=458275071&page2=Golimumab","#cite_note-1","/wiki/Human","/wiki/Monoclonal_antibody","/wiki/Immunosuppressive_drug","/wiki/Tumor_necrosis_factor_alpha","#cite_note-2","/wiki/TNF_inhibitor","/wiki/Centocor","#cite_note-3","#cite_note-4","/wiki/Rheumatoid_arthritis","/wiki/Psoriatic_arthritis","/wiki/Ankylosing_spondylitis","#cite_note-ap-5","/wiki/Johnson_%26_Johnson","http://insciences.org/article.php?article_id=7069","/wiki/European_Medicines_Agency","#cite_note-6","/wiki/Merck_%26_Co,_Inc.","#cite_note-7","#cite_note-8","#cite_note-9","/w/index.php?title=Golimumab&action=edit&section=1","/w/index.php?title=Golimumab&veaction=edit&section=1","/wiki/Methotrexate","#cite_note-golim-10","/w/index.php?title=Golimumab&action=edit&section=2","/w/index.php?title=Golimumab&veaction=edit&section=2","#cite_ref-1","http://www.landesbioscience.com/journals/mabs/article/9286/","/wiki/Digital_object_identifier","http://dx.doi.org/10.4161%2Fmabs.1.5.9286","#cite_ref-2","http://www.ama-assn.org/ama1/pub/upload/mm/365/golimumab.doc","#cite_ref-3","http://www.centocororthobiotech.com/cobi/viewDocumentByTitleAlias.html?title=PR_SIMPONI_CANADIAN_APPROVAL","#cite_ref-4","http://www.drugs.com/newdrugs/simponi-golimumab-receives-fda-approval-first-once-monthly-anti-tnf-rheumatoid-arthritis-psoriatic-1329.html","#cite_ref-ap_5-0","http://www.nctimes.com/business/article_95a13fa4-8492-5080-8ee0-bbce644fb21b.html","/wiki/North_County_Times","/wiki/Lee_Enterprises","/wiki/Associated_Press","#cite_ref-6","http://sev.prnewswire.com/retail/20080415/NYTU07615042008-1.html","#cite_ref-7","http://www.latimes.com/business/la-fi-arthritis25-2009apr25,0,1270502.story","#cite_ref-8","http://www.reuters.com/article/idUSN0722206120100907","#cite_ref-9","http://www.emea.europa.eu/humandocs/Humans/EPAR/simponi/simponi.htm","/wiki/European_Medicines_Agency","#cite_ref-golim_10-0","http://adisonline.com/biodrugs/abstract/2009/23020/Golimumab__In_the_Treatment_of_Rheumatoid.5.aspx","/wiki/Digital_object_identifier","http://dx.doi.org/10.2165%2F00063030-200923020-00005","/wiki/Template:Immunosuppressants","/wiki/Template_talk:Immunosuppressants","//en.wikipedia.org/w/index.php?title=Template:Immunosuppressants&action=edit","/wiki/Immunomodulator","/wiki/Immunosuppressive_drug","/wiki/Immunosuppressant","/wiki/ATC_code_L04","/wiki/Antimetabolite","/wiki/Purine_synthesis_inhibitor","/wiki/Azathioprine","/wiki/Mycophenolic_acid","/wiki/Pyrimidine_synthesis_inhibitor","/wiki/Leflunomide","/wiki/Teriflunomide","/wiki/Antifolate","/wiki/Methotrexate","/wiki/Macrolide","/wiki/Interleukin_2","/wiki/FKBP","/wiki/Cyclophilin","/wiki/Calcineurin","/wiki/Tacrolimus","/wiki/Ciclosporin","/wiki/Pimecrolimus","/wiki/Abetimus","/wiki/Gusperimus","/wiki/Thalidomide","/wiki/Lenalidomide","/wiki/Interleukin_1_receptor_antagonist","/wiki/Anakinra","/wiki/Mammalian_target_of_rapamycin","/wiki/Sirolimus","/wiki/Everolimus","/wiki/Ridaforolimus","/wiki/Temsirolimus","/wiki/Umirolimus","/wiki/Zotarolimus","/wiki/Antibody","/wiki/Monoclonal_antibodies","/wiki/Complement_component_5","/wiki/Eculizumab","/wiki/TNF_inhibitor","/wiki/Adalimumab","/wiki/Afelimomab","/wiki/Certolizumab_pegol","/wiki/Infliximab","/wiki/Nerelimomab","/wiki/Interleukin_5","/wiki/Mepolizumab","/wiki/Immunoglobulin_E","/wiki/Omalizumab","/wiki/Interferon","/wiki/Faralimomab","/wiki/Interleukin_6","/wiki/Elsilimomab","/wiki/Interleukin_12","/wiki/Interleukin_23","/wiki/Lebrikizumab","/wiki/Ustekinumab","/wiki/CD3_(immunology)","/wiki/Muromonab-CD3","/wiki/Otelixizumab","/wiki/Teplizumab","/wiki/Visilizumab","/wiki/CD4","/wiki/Clenoliximab","/wiki/Keliximab","/wiki/Zanolimumab","/wiki/CD11a","/wiki/Efalizumab","/wiki/CD18","/wiki/Erlizumab","/wiki/CD20","/wiki/Afutuzumab","/wiki/Rituximab","/wiki/Ocrelizumab","/wiki/Pascolizumab","/wiki/CD23","/wiki/Gomiliximab","/wiki/Lumiliximab","/wiki/CD40_(protein)","/wiki/Teneliximab","/wiki/Toralizumab","/wiki/L-selectin","/wiki/Aselizumab","/wiki/CD80","/wiki/Galiximab","/wiki/Basigin","/wiki/Gavilimomab","/wiki/CD154","/wiki/Ruplizumab","/wiki/Belimumab","/wiki/CTLA-4","/wiki/Ipilimumab","/wiki/Tremelimumab","/wiki/Chloramphenicol_acetyltransferase","/wiki/Bertilimumab","/wiki/Lerdelimumab","/wiki/Metelimumab","/wiki/Integrin","/wiki/Natalizumab","/wiki/Interleukin-6_receptor","/wiki/Tocilizumab","/wiki/Lymphocyte_function-associated_antigen_1","/wiki/Odulimomab","/wiki/IL-2_receptor","/wiki/Basiliximab","/wiki/Daclizumab","/wiki/Inolimomab","/wiki/T_cell","/wiki/Zolimomab_aritox","/wiki/Atorolimumab","/wiki/Cedelizumab","/wiki/Fontolizumab","/wiki/Maslimomab","/wiki/Morolimumab","/wiki/Pexelizumab","/wiki/Reslizumab","/wiki/Rovelizumab","/wiki/Siplizumab","/wiki/Talizumab","/wiki/Telimomab_aritox","/wiki/Vapaliximab","/wiki/Vepalimomab","/wiki/Polyclonal_antibodies","/wiki/Anti-thymocyte_globulin","/wiki/Anti-lymphocyte_globulin","/wiki/Fusion_protein","/wiki/CTLA-4","/wiki/Abatacept","/wiki/Belatacept","/wiki/TNF_inhibitor","/wiki/Etanercept","/wiki/Pegsunercept","/wiki/Aflibercept","/wiki/Alefacept","/wiki/Rilonacept","/wiki/Template:Medicine_navs","/wiki/Lymphocyte","/wiki/Template:Lymphocytes","/wiki/Template:Lymphocytic_immune_system","/wiki/Template:Autoantigens","/wiki/Template:Autoantibodies","/wiki/Template:Complement_system","/wiki/Template:Immunoglobulin_superfamily_immune_receptors","/wiki/Template:Lymphoid_and_complement_immunodeficiency","/wiki/Template:Immunoproliferative_immunoglobulin_disorders","/wiki/Template:Hypersensitivity_and_autoimmune_diseases","/wiki/Template:Lymphoid_malignancy","/wiki/Template:Immunologic_techniques_and_tests","/wiki/Template:Immunostimulants","/wiki/Template:Immunosuppressants","/wiki/Template:Monoclonals_for_immune_system","/wiki/Template_talk:Monoclonals_for_immune_system","//en.wikipedia.org/w/index.php?title=Template:Monoclonals_for_immune_system&action=edit","/wiki/Monoclonal_antibodies","/wiki/Immune_system","/wiki/Immune_system","/wiki/Immunosuppression","/wiki/Adalimumab","/wiki/Anifrolumab","/wiki/Atorolimumab","/wiki/Belimumab","/wiki/Brodalumab","/wiki/Carlumab","/wiki/Dupilumab","/wiki/Eldelumab","/wiki/Fresolimumab","/wiki/Lerdelimumab","/wiki/Lirilumab","/wiki/Mavrilimumab","/wiki/Metelimumab","/wiki/Morolimumab","/wiki/Namilumab","/wiki/Oxelumab","/wiki/Placulumab","/wiki/Sarilumab","/wiki/Sifalimumab","/wiki/Tabalumab","/wiki/Ipilimumab","/wiki/Tremelimumab","/wiki/Nivolumab","/wiki/Urelumab","/wiki/Bertilimumab","/wiki/Zanolimumab","/wiki/Afelimomab","/wiki/Elsilimomab","/wiki/Faralimomab","/wiki/Gavilimomab","/wiki/Inolimomab","/wiki/Maslimomab","/wiki/Nerelimomab","/wiki/Odulimomab","/wiki/Telimomab_aritox","/wiki/Vepalimomab","/wiki/Zolimomab_aritox","/wiki/Chimeric_antibody","/wiki/Basiliximab","/wiki/Clenoliximab","/wiki/Galiximab","/wiki/Gomiliximab","/wiki/Infliximab","/wiki/Keliximab","/wiki/Lumiliximab","/wiki/Priliximab","/wiki/Teneliximab","/wiki/Vapaliximab","/wiki/Humanized_antibody","/wiki/Aselizumab","/wiki/Apolizumab","/wiki/Benralizumab","/wiki/Cedelizumab","/wiki/Certolizumab_pegol","/wiki/Daclizumab","/wiki/Eculizumab","/wiki/Efalizumab","/wiki/Epratuzumab","/wiki/Erlizumab","/wiki/Etrolizumab","/wiki/Fontolizumab","/wiki/Itolizumab","/wiki/Lambrolizumab","/wiki/Lampalizumab","/wiki/Ligelizumab","/wiki/Mepolizumab","/wiki/Mogamulizumab","/wiki/Natalizumab","/wiki/Ocrelizumab","/wiki/Omalizumab","/wiki/Ozoralizumab","/wiki/Pascolizumab","/wiki/Pateclizumab","/wiki/Pexelizumab","/wiki/Pidilizumab","/wiki/PRO_140","/wiki/Reslizumab","/wiki/Rontalizumab","/wiki/Rovelizumab","/wiki/Ruplizumab","/wiki/Quilizumab","/wiki/Samalizumab","/wiki/Siplizumab","/wiki/Talizumab","/wiki/Teplizumab","/wiki/Tocilizumab","/wiki/Toralizumab","/wiki/Tregalizumab","/wiki/Vatelizumab","/wiki/Vedolizumab","/wiki/Visilizumab","/wiki/TGN1412","/wiki/Ibalizumab","/wiki/Otelixizumab","/wiki/Interleukin","/wiki/Briakinumab","/wiki/Canakinumab","/wiki/Fezakinumab","/wiki/Guselkumab","/wiki/Secukinumab","/wiki/Sirukumab","/wiki/Tralokinumab","/wiki/Ustekinumab","/wiki/Anrukinzumab","/wiki/Clazakizumab","/wiki/Enokizumab","/wiki/Gevokizumab","/wiki/Ixekizumab","/wiki/Lebrikizumab","/wiki/Olokizumab","/wiki/Perakizumab","/wiki/Tildrakizumab","/wiki/Lesion","/wiki/Besilesomab","/wiki/Technetium_(99mTc)_fanolesomab","/wiki/Lemalesomab","/wiki/Technetium_(99mTc)_sulesomab","/wiki/List_of_World_Health_Organization_Essential_Medicines","/wiki/List_of_withdrawn_drugs","/wiki/Clinical_trial","/wiki/Clinical_trial#Phase_III","/wiki/Clinical_trial#Phase_II","/wiki/Template:Medicine_navs","/wiki/Lymphocyte","/wiki/Template:Lymphocytes","/wiki/Template:Lymphocytic_immune_system","/wiki/Template:Autoantigens","/wiki/Template:Autoantibodies","/wiki/Template:Complement_system","/wiki/Template:Immunoglobulin_superfamily_immune_receptors","/wiki/Template:Lymphoid_and_complement_immunodeficiency","/wiki/Template:Immunoproliferative_immunoglobulin_disorders","/wiki/Template:Hypersensitivity_and_autoimmune_diseases","/wiki/Template:Lymphoid_malignancy","/wiki/Template:Immunologic_techniques_and_tests","/wiki/Template:Immunostimulants","/wiki/Template:Immunosuppressants","/wiki/File:Inmunoglobulina.png","//upload.wikimedia.org/wikipedia/commons/thumb/3/3b/Inmunoglobulina.png/37px-Inmunoglobulina.png","/wiki/Monoclonal_antibody","/wiki/Wikipedia:Stub","//en.wikipedia.org/w/index.php?title=Golimumab&action=edit","/wiki/Template:Monoclonal-antibody-stub","/wiki/Template_talk:Monoclonal-antibody-stub","//en.wikipedia.org/w/index.php?title=Template:Monoclonal-antibody-stub&action=edit","/wiki/File:Cisplatin-3D-vdW.png","//upload.wikimedia.org/wikipedia/commons/thumb/7/77/Cisplatin-3D-vdW.png/40px-Cisplatin-3D-vdW.png","/wiki/Antineoplastic","/wiki/Immunomodulator","/wiki/Pharmaceutical_drug","/wiki/Wikipedia:Stub","//en.wikipedia.org/w/index.php?title=Golimumab&action=edit","/wiki/Template:Antineoplastic-drug-stub","/wiki/Template_talk:Antineoplastic-drug-stub","//en.wikipedia.org/w/index.php?title=Template:Antineoplastic-drug-stub&action=edit","//en.wikipedia.org/w/index.php?title=Special:CentralAutoLogin/start&type=1x1&from=enwiki","http://en.wikipedia.org/w/index.php?title=Golimumab&oldid=541482262","/wiki/Help:Categories","/wiki/Category:Johnson_%26_Johnson","/wiki/Category:Centocor","/wiki/Category:TNF_inhibitors","/wiki/Category:Monoclonal_antibody_stubs","/wiki/Category:Antineoplastic_and_immunomodulating_drug_stubs","/wiki/Category:Articles_with_changed_CASNo","/wiki/Category:Chemical_compounds_which_do_not_have_a_ChemSpiderID","/wiki/Category:Articles_with_changed_EBI_identifier","/wiki/Category:Drugboxes_which_contain_changes_to_verified_fields","/w/index.php?title=Special:UserLogin&returnto=Golimumab&type=signup","/w/index.php?title=Special:UserLogin&returnto=Golimumab","/wiki/Golimumab","/wiki/Talk:Golimumab","#","/wiki/Golimumab","/w/index.php?title=Golimumab&action=edit","/w/index.php?title=Golimumab&veaction=edit","/w/index.php?title=Golimumab&action=history","#","/w/index.php","//bits.wikimedia.org/static-1.22wmf12/skins/vector/images/search-ltr.png?303-4","/wiki/Main_Page","/wiki/Main_Page","/wiki/Portal:Contents","/wiki/Portal:Featured_content","/wiki/Portal:Current_events","/wiki/Special:Random","https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&utm_medium=sidebar&utm_campaign=C13_en.wikipedia.org&uselang=en","/wiki/Help:Contents","/wiki/Wikipedia:About","/wiki/Wikipedia:Community_portal","/wiki/Special:RecentChanges","//en.wikipedia.org/wiki/Wikipedia:Contact_us","/wiki/Special:WhatLinksHere/Golimumab","/wiki/Special:RecentChangesLinked/Golimumab","/wiki/Wikipedia:File_Upload_Wizard","/wiki/Special:SpecialPages","/w/index.php?title=Golimumab&oldid=541482262","/w/index.php?title=Golimumab&action=info","//www.wikidata.org/wiki/Q413879","/w/index.php?title=Special:Cite&page=Golimumab&id=541482262","/w/index.php?title=Special:Book&bookcmd=book_creator&referer=Golimumab","/w/index.php?title=Special:Book&bookcmd=render_article&arttitle=Golimumab&oldid=541482262&writer=rl","/w/index.php?title=Golimumab&printable=yes","//ar.wikipedia.org/wiki/%D8%BA%D9%88%D9%84%D9%8A%D9%85%D9%88%D9%85%D8%A7%D8%A8","//de.wikipedia.org/wiki/Golimumab","//es.wikipedia.org/wiki/Golimumab","//fr.wikipedia.org/wiki/Golimumab","//it.wikipedia.org/wiki/Golimumab","//ja.wikipedia.org/wiki/%E3%82%B4%E3%83%AA%E3%83%A0%E3%83%9E%E3%83%96","#","//www.wikidata.org/wiki/Q413879#sitelinks-wikipedia","//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License","//creativecommons.org/licenses/by-sa/3.0/","//wikimediafoundation.org/wiki/Terms_of_Use","//wikimediafoundation.org/wiki/Privacy_policy","//www.wikimediafoundation.org/","//wikimediafoundation.org/wiki/Privacy_policy","/wiki/Wikipedia:About","/wiki/Wikipedia:General_disclaimer","//en.wikipedia.org/wiki/Wikipedia:Contact_us","//en.m.wikipedia.org/wiki/Golimumab","//wikimediafoundation.org/","//bits.wikimedia.org/images/wikimedia-button.png","//www.mediawiki.org/","//bits.wikimedia.org/static-1.22wmf12/skins/common/images/poweredby_mediawiki_88x31.png","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=scripts&skin=vector&*"],"instances":[],"pdf":[],"categories":["Johnson & Johnson","Centocor","TNF inhibitors"],"headings":["Efficacy","References"],"image":["//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png","//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/14px-X_mark.svg.png","//upload.wikimedia.org/wikipedia/commons/thumb/3/3b/Inmunoglobulina.png/37px-Inmunoglobulina.png","//upload.wikimedia.org/wikipedia/commons/thumb/7/77/Cisplatin-3D-vdW.png/40px-Cisplatin-3D-vdW.png","//en.wikipedia.org/w/index.php?title=Special:CentralAutoLogin/start&type=1x1&from=enwiki","//bits.wikimedia.org/static-1.22wmf12/skins/vector/images/search-ltr.png?303-4","//bits.wikimedia.org/images/wikimedia-button.png","//bits.wikimedia.org/static-1.22wmf12/skins/common/images/poweredby_mediawiki_88x31.png"],"tags":[],"members":[],"related":["TNF&alpha;","Subcutaneous_injection","KDa","Human","Monoclonal_antibody","Immunosuppressive_drug","Tumor_necrosis_factor_alpha","TNF_inhibitor","Centocor","Rheumatoid_arthritis","Psoriatic_arthritis","Ankylosing_spondylitis","Johnson_&_Johnson","European_Medicines_Agency","Merck_&_Co,_Inc.","European_Medicines_Agency","Methotrexate"]}